Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HS.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.277NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.587NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used